BRYCELAB
PAUL BRYCE
-Who:What:Why-
ABOUT ME
​I am a Scotland-born scientist working in the United States since 1999. While my background is pharmacology, my passion & opportunities drove me into immunology. I specialized in allergy research for much of my career, including asthma, eczema and food allergies.
​​
-
Over 18 years leadership experience in translational research across academia, pharma, and biotech.
-
Proven success in leading innovation-focused, research projects and consortia.
-
Strong communicator, team leader and mentor.
PAST EXPERIENCE
Past Roles
Executive Director, IMMUNEID
May 2022 - Jan 2023
Head of Discovery for ImmuneID, a patient focused biotech company defining precision medicine through autoantibody target identification using next generation phage display approaches.
Senior Director, SANOFI
June 2017 - May 2022
Lead four teams of scientists as Head of Type 2 Inflammation & Fibrosis within the Immunology & Inflammation Therapeutic Area. Oversaw 20-25 people driving the innovation and target credentialing to enter the Sanofi drug development pipeline and progress to IND submission and clinical development.
Faculty, NORTHWESTERN UNIVERSITY
May 2005 - June 2017
Faculty in the Department of Medicine of Feinberg Medical School. Based in the Division of Allergy & Immunology and led a research operation focused on translational medicine of allergic diseases. Awarded tenure in 2015, having R01-level funding for over 10 years.
Mentored 5 students to PhD award, as well as many clinical and postdoctoral fellows.